| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.08. | MEDIROM Healthcare Technologies - ADS reports Q2 results | 1 | Seeking Alpha | ||
| 27.08. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.08. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 25.06. | MEDIROM Healthcare Technologies Inc.: MEDIROM MOTHER Labs Expands Deployment of "REMONY" Remote Health Monitoring System in JGSDF 8th Division | 1 | GlobeNewswire (USA) | ||
| 25.06. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | MEDIROM Healthcare Technologies Inc.: MEDIROM Group Reports Q1 2026 Results | 220 | GlobeNewswire (Europe) | TOKYO, May 28, 2026 (GLOBE NEWSWIRE) -- This report presents an overview of our business performance and key performance indicators (KPIs) for the first quarter of 2026 (January-March 2026). It also... ► Artikel lesen | |
| 28.05. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| MEDIROM HEALTHCARE TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 22.04. | Medirom Healthcare Technologies Inc. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 04.12.25 | MEDIROM Healthcare Technologies Inc.: MEDIROM Mother Labs Partners with TD SYNNEX to Accelerate National Adoption of "MOTHER Bracelet" and "REMONY" | 479 | GlobeNewswire (Europe) | TOKYO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ("MEDIROM") today announced that its subsidiary, MEDIROM MOTHER Labs Inc. ("MOTHER Labs"), which develops... ► Artikel lesen | |
| 29.10.25 | MEDIROM Healthcare Technologies Inc.: MEDIROM to Launch New Treasury Strategy Utilizing Cryptocurrency | 961 | GlobeNewswire (Europe) | TOKYO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc., (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on the Nasdaq Stock Market under the ticker... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | Alignment Healthcare earns 4-Star or higher ratings for six plans | ||
| HEARTFLOW | 47,590 | -0,08 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| AVEANNA HEALTHCARE | 12,235 | -0,04 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | -0,05 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| FRESENIUS | 42,480 | +2,14 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| BETA BIONICS | 17,440 | +0,06 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,620 | +2,45 % | Fresenius Medical Care: Plötzlicher Führungswechsel schürt Zweifel an Zukunft - Kurs bricht weiter ein | Der überraschende Führungswechsel bei Fresenius Medical Care lässt die Aktie abstürzen und schürt Spekulationen über einen radikalen Kurswechsel im angeschlagenen Dialysegeschäft. Anleger und Analysten... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning | ||
| NEUROPACE | 12,390 | 0,00 % | KeyBanc initiates NeuroPace stock coverage with overweight rating |